PBX1 acts as an upstream transcriptional regulator that suppresses osteogenic differentiation in part by activating HMGB1, and pharmacological inhibition of PBX1 restores osteogenic potential.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: